Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans

Goedert, M., Jakes, R., Spillantini, M. G., Hasegawa, M., Smith, M. J., Crowther, R. A.·1996·Nature
DOI 10.1038/383550a0

Cited by (1,000)

Items 301–400 of 1,000

  1. Glycan Determinants of Heparin-Tau Interaction
    Zhao, Jing, Huvent, Isabelle, Lippens, Guy, Eliezer, David, Zhang, Anqiang, Li, Quanhong, Tessier, Peter, Linhardt, Robert J., Zhang, Fuming, Wang, Chunyu · 2017 · Biophysical Journal
  2. Heparin-induced tau filaments are structurally heterogeneous and differ from Alzheimer's disease filaments
    Fichou, Yann, Vigers, Michael, Goring, Andrew K., Eschmann, Neil A., Han, Songi · 2018 · Chemical Communications
  3. Proteoglycans in the central nervous system: Role in development, neural repair, and Alzheimer's disease
    Cui Hao, Craig G. Freeman, Glenn A. Jacobson, David Henry Small · 2013 · IUBMB Life
  4. Heparin-induced Conformational Change in Microtubule-associated Protein Tau as Detected by Chemical Cross-linking and Phosphopeptide Mapping
    Hemant K. Paudel, Wei Shan Li · 1999 · Journal of Biological Chemistry
  5. High-throughput cryo-EM structure determination of amyloids
    Sofia Lövestam, Sjors H. W. Scheres · 2022 · Faraday Discussions
  6. Tau-induced neurodegeneration: mechanisms and targets
    Cindy Beharry, Leah S. Cohen, Jing Di, Kawsar Ibrahim, Susan Briffa-Mirabella, Alejandra del C. Alonso · 2014 · Neuroscience Bulletin
  7. Co-factor-free aggregation of tau into seeding-competent RNA-sequestering amyloid fibrils
    Pijush Chakraborty, Gwladys Rivière, Shu Liu, Alain Ibáñez de Opakua, Rıza Dervişoğlu, Alina Hebestreit, Loren B. Andreas, Ina Maja Vorberg, Markus Zweckstetter · 2021 · Nature Communications
  8. Conformational Features of Tau Fibrils from Alzheimer’s Disease Brain Are Faithfully Propagated by Unmodified Recombinant Protein
    Olga A. Morozova, Zachary M. March, Anne Skaja Robinson, David W. Colby · 2013 · Biochemistry
  9. Cell-based Models To Investigate Tau Aggregation
    Sungsu Lim, Md. Mamunul Haque, Do‐Hee Kim, Dong Jin Kim, Yun Kyung Kim · 2014 · Computational and Structural Biotechnology Journal
  10. Medicinal chemistry approaches for the treatment and prevention of Alzheimer's disease
    Сергей Олегович Бачурин · 2002 · Medicinal Research Reviews
  11. TRPV1 activation alleviates cognitive and synaptic plasticity impairments through inhibiting AMPAR endocytosis in APP23/PS45 mouse model of Alzheimer’s disease
    Du, Yehong, Fu, Min, Huang, Zhilin, Tian, Xin, Li, Junjie, Pang, Yayan, Song, Weihong, Tian Wang, Yu, Dong, Zhifang · 2020 · Aging Cell
  12. RNA Binds to Tau Fibrils and Sustains Template-Assisted Growth
    Paul D. Dinkel, Michael R. Holden, Nadira Matin, Martin Margittai · 2015 · Biochemistry
  13. Microtubule-binding core of the tau protein
    Nadia El Mammeri, Aurelio James Dregni, Pu Duan, Harrison K. Wang, Mei Hong · 2022 · Science Advances
  14. Amyloid-like aggregates of neuronal tau induced by formaldehyde promote apoptosis of neuronal cells
    Chun Lai Nie, Xing Sheng Wang, Ying Min Liu, Sarah Perrett, Rong Qiao He · 2007 · BMC Neuroscience
  15. Characteristics of Tau Oligomers
    Yan Ren, Naruhiko Sahara · 2013 · Frontiers in Neurology
  16. Assembly of paired helical filaments from mouse tau: implications for the neurofibrillary pathology in transgenic mouse models for Alzheimer's disease
    T. Kampers, Menelas N. Pangalos, Hugo Geerts, Hans Wiech, Eva‐Maria Mandelkow · 1999 · FEBS Letters
  17. Collagen XVIII: a Novel Heparan Sulfate Proteoglycan Associated with Vascular Amyloid Depositions and Senile Plaques in Alzheimer's Disease Brains
    Jack van Horssen, Micha M.M. Wilhelmus, Ritva Heljäsvaara, Taina A. Pihlajaniemi, Pieter Wesseling, Robert M.W. de Waal, Marcel M. Verbeek · 2002 · Brain Pathology
  18. Tramiprosate, a drug of potential interest for the treatment of Alzheimer's disease, promotes an abnormal aggregation of tau
    Ismael Santa‐María, Félix Hernández, Joaquín Del Rio, Francisco Javier Moreno, Jesús Ávila · 2007 · Molecular Neurodegeneration
  19. Formation of the Antithrombin Heterodimer In Vivo and the Onset of Thrombosis
    Aiwu Zhou, James A. Huntington, Robin W. Carrell · 1999 · Blood
  20. Localization of frontotemporal dementia with parkinsonism in an Australian kindred to chromosome 17q21–22
    Baker, Matt, Kwok, John B. J., Kucera, Steve, Crook, Richard, Farrer, Matthew, Houlden, Henry, Isaacs, Adrian, Lincoln, Sarah, Onstead, Luisa, Hardy, John et al. · 1997 · Annals of Neurology
  21. The role of heparan sulfates in protein aggregation and their potential impact on neurodegeneration
    Auriane Maïza, Sandrine Chantepie, Cecilia Vera, Alexandre Fifre, Minh Bao Huynh, Olivier Stettler, Mohand Ouidir Ouidja, Dulce Papy-García · 2018 · FEBS Letters
  22. Tau (297‐391) forms filaments that structurally mimic the core of paired helical filaments in Alzheimer’s disease brain
    Youssra K. Al‐Hilaly, Bronwen E. Foster, Luca Biasetti, Liisa Lutter, Saskia J. Pollack, Janet E. Rickard, John M. D. Storey, Charles R. Harrington, Wei‐Feng Xue, Claude M. Wischik et al. · 2019 · FEBS Letters
  23. Hyperphosphorylated tau self-assembles into amorphous aggregates eliciting TLR4-dependent responses
    Meng, Jonathan X., Zhang, Yu, Saman, Dominik, Haider, Arshad M., De, Suman, Sang, Jason C., Brown, Karen, Jiang, Kun, Humphrey, Jane, Julian, Linda et al. · 2022 · Nature Communications
  24. Formaldehyde at Low Concentration Induces Protein Tau into Globular Amyloid-Like Aggregates In Vitro and In Vivo
    Chun Lai Nie, Wei Yan, Xinyong Chen, Yan Ying Liu, Wen Dui, Ying Min Liu, Martyn C. Davies, Saul J. B. Tendler, Rong He · 2007 · PLoS ONE
  25. Signature of an aggregation-prone conformation of tau
    Neil A. Eschmann, Elka R. Georgieva, Pritam Ganguly, Peter P. Borbat, Maxime D. Rappaport, Yaşar Akdoğan, Jack H. Freed, Joan‐Emma Shea, Songi Han · 2017 · Scientific Reports
  26. Sequential phosphorylation of tau protein by cAMP‐dependent protein kinase and SAPK4/p38δ or JNK2 in the presence of heparin generates the AT100 epitope
    Hirotaka Yoshida, Michel Goedert · 2006 · Journal of Neurochemistry
  27. Fibrillogenic Nuclei Composed of P301L Mutant Tau Induce Elongation of P301L Tau but Not Wild-type Tau
    Hirofumi Aoyagi, Masato Hasegawa, Akira Tamaoka · 2007 · Journal of Biological Chemistry
  28. Side Chain-dependent Stacking Modulates Tau Filament Structure
    Martin Margittai, Ralf Langen · 2006 · Journal of Biological Chemistry
  29. Variable phenotypic expression and extensive tau pathology in two families with the novel tau mutation L315R
    Esther van Herpen, Sonia M. Rosso, Lies‐Anne Serverijnen, Hirotaka Yoshida, Guido J. Breedveld, Raoul van de Graaf, Wouter Kamphorst, Rivka Ravid, Rob Willemsen, Dennis Dooijes et al. · 2003 · Annals of Neurology
  30. Fyn Kinase Controls Tau Aggregation In Vivo
    Adam Briner, Jürgen Götz, Juan Carlos Polanco · 2020 · Cell Reports
  31. The Relationship between Amyloid and Tau
    Hardy, John · 2003 · Journal of Molecular Neuroscience
  32. Binding of the three-repeat domain of tau to phospholipid membranes induces an aggregated-like state of the protein
    Georg Künze, Patrick Barré, Holger A. Scheidt, Lars Thomas, David Eliezer, Daniel Huster · 2012 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  33. Sulfated Polysaccharides Promote the Assembly of Amyloid β1–42 Peptide into Stable Fibrils of Reduced Cytotoxicity
    Ramona Bravo, Muriel Arimon, Juan José Valle‐Delgado, Raquel Garcı́a, Núria Durany, Susanna Castel, Montserrat Cruz, Salvador Ventura, Xavier Fernàndez‐Busquets · 2008 · Journal of Biological Chemistry
  34. Inhibition of the Self-Assembly of Aβ and of Tau by Polyphenols: Mechanistic Studies
    Qiuchen Zheng, Micheal T. Kebede, Merc M. Kemeh, Saadman Islam, Bethany Lee, Stuart D. Bleck, Liliana A. Wurfl, Noel D. Lazo · 2019 · Molecules
  35. Liquid-liquid phase transitions and amyloid aggregation in proteins related to cancer and neurodegenerative diseases
    2019 · Advances in protein chemistry and structural biology
  36. Interaction of 14-3-3ζ with Microtubule-Associated Protein Tau within Alzheimer’s Disease Neurofibrillary Tangles
    Hamid Y. Qureshi, Tong Li, Ryen MacDonald, Chulmin Cho, Nicole M. Leclerc, Hemant K. Paudel · 2013 · Biochemistry
  37. Protein structural and surface water rearrangement constitute major events in the earliest aggregation stages of tau
    Ànna Pavlova, Chi‐Yuan Cheng, Maia Kinnebrew, John Lew, Frederick W. Dahlquist, Songi Han · 2015 · Proceedings of the National Academy of Sciences
  38. Regulation of neuronal microtubule dynamics by tau: Implications for tauopathies
    Anuradha Venkatramani, Dulal Panda · 2019 · International Journal of Biological Macromolecules
  39. Diverse functions of perineuronal nets
    Karetko, Magdalena, Skangiel-Kramska, Jolanta · 2009 · Acta Neurobiologiae Experimentalis
  40. Changes in the ageing brain in health and disease
    Brian H. Anderton · 1997 · Philosophical Transactions of the Royal Society B Biological Sciences
  41. Comprehensive analysis of differentially expressed profiles of Alzheimer’s disease associated circular RNAs in an Alzheimer’s disease mouse model
    Jin-Lan Huang, Mei-Chun Qin, Yan Zhou, Zhehao Xu, Si‐Man Yang, Fan Zhang, Jing Zhong, Ming-Kun Liang, Ben Chen, Wenyan Zhang et al. · 2018 · Aging
  42. The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model
    Patricia Yuste‐Checa, Victoria A. Trinkaus, Irene Riera-Tur, Rahmi Imamoglu, Theresa Schaller, Huping Wang, Irina Dudanova, Mark S. Hipp, Andreas Bracher, F. Ulrich Hartl · 2021 · Nature Communications
  43. The Neurofibrillary Pathology of Alzheimer's Disease
    Michel Goedert · 1997 · The Neuroscientist
  44. A 31-residue peptide induces aggregation of tau's microtubule-binding region in cells
    Jan Stöhr, Haifan Wu, Mimi Nick, Yibing Wu, Manasi Bhate, Carlo Condello, Noah Johnson, Jeffrey M. Rodgers, Thomas Lemmin, Srabasti Acharya et al. · 2017 · Nature Chemistry
  45. Fluent molecular mixing of Tau isoforms in Alzheimer’s disease neurofibrillary tangles
    Aurelio James Dregni, Pu Duan, Hong Wei Xu, Lakshmi N. Changolkar, Nadia El Mammeri, Virginia M.‐Y. Lee, Mei Hong · 2022 · Nature Communications
  46. A Soluble Oligomer of Tau Associated with Fiber Formation Analyzed by NMR
    Dylan W. Peterson, Hongjun Zhou, Frederick W. Dahlquist, John Lew · 2008 · Biochemistry
  47. Inhibition of Tau Filament Formation by Conformational Modulation
    Elias Akoury, Michał J. Gajda, Marcus Pickhardt, Jacek Biernat, Soraya Pornsuwan, Christian Griesinger, Eckhard Mandelkow�, Markus Zweckstetter · 2013 · Journal of the American Chemical Society
  48. Conformational basis for asymmetric seeding barrier in filaments of three- and four-repeat tau
    Siddiqua, Ayisha, Luo, Yin, Meyer, Virginia, Swanson, Michael A., Yu, Xiang, Wei, Guanghong, Zheng, Jie, Eaton, Gareth R., Ma, Buyong, Nussinov, Ruth et al. · 2012 · Journal of the American Chemical Society
  49. Chapter 21 Neurofibrillary pathology of Alzheimer's disease and other tauopathies
    Michel Goedert · 1998 · Progress in brain research
  50. Liquid–Liquid Phase Separation of Tau Protein Is Encoded at the Monomeric Level
    Xuewei Dong, Santu Bera, Qin Qiao, Yiming Tang, Zenghui Lao, Yin Luo, Ehud Gazit, Guanghong Wei · 2021 · The Journal of Physical Chemistry Letters
  51. Role of Cysteine-291 and Cysteine-322 in the Polymerization of Human Tau into Alzheimer-like Filaments
    Keshab Bhattacharya, Kenneth B. Rank, DAVID B. EVANS, Satish K. Sharma · 2001 · Biochemical and Biophysical Research Communications
  52. Structure, Stability, and Aggregation of Paired Helical Filaments from Tau Protein and FTDP-17 Mutants Probed by Tryptophan Scanning Mutagenesis*
    Li Li, M. von Bergen, E. Mandelkow, E. Mandelkow · 2002 · Journal of Biological Chemistry
  53. Frontotemporal Dementia with Tau Pathology
    Laura Gasparini, Beatrice Terni, Maria Grazia Spillantini · 2007 · Neurodegenerative Diseases
  54. Potential mechanisms and implications for the formation of tau oligomeric strains
    Julia E. Gerson, Amritpal K. Mudher, Rakez Kayed · 2016 · Critical Reviews in Biochemistry and Molecular Biology
  55. Ordered Assembly of Tau Protein and Neurodegeneration
    Michel Goedert, Maria Grazia Spillantini · 2019 · Advances in experimental medicine and biology
  56. Characterization of tau fibrillization in vitro
    Shaohua Xu, Kurt R. Brunden, John Q. Trojanowski, Virginia M.‐Y. Lee · 2010 · Alzheimer s & Dementia
  57. Phosphorylation by Neuronal cdc2-like Protein Kinase Promotes Dimerization of Tau Protein in Vitro
    Hemant K. Paudel · 1997 · Journal of Biological Chemistry
  58. Neurodegenerative diseases with cytoskeletal pathology: A biochemical classification
    Dennis W. Dickson · 1997 · Annals of Neurology
  59. Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43
    Airi Tarutani, Tadashi Adachi, Hiroyasu Akatsu, Yoshio Hashizume, Kazuko Hasegawa, Yuko Saito, Andrew Robinson, David M. A. Mann, Mari Yoshida, Shigeo Murayama et al. · 2022 · Acta Neuropathologica
  60. Intrinsically Disordered Proteins in the Neurodegenerative Processes: Formation of Tau Protein Paired Helical Filaments and Their Analysis
    Rostislav Škrabana, Jozef Ševčı́k, Michal Novák · 2006 · Cellular and Molecular Neurobiology
  61. Modulation of Aβ 42 fìbrillogenesis by glycosaminoglycan structure
    Juan José Valle‐Delgado, Mercedes Alfonso‐Prieto, Natalia Sánchez de Groot, Salvador Ventura, Josep Samitier, Carme Rovira, Xavier Fernàndez‐Busquets · 2010 · The FASEB Journal
  62. Zeta 14-3-3 protein favours the formation of human tau fibrillar polymers
    Félix Hernández, Raquel Cuadros, Jesús Ávila · 2004 · Neuroscience Letters
  63. Glycosaminoglycans from Alzheimer’s disease hippocampus have altered capacities to bind and regulate growth factors activities and to bind tau
    Huynh, Minh Bao, Ouidja, Mohand Ouidir, Chantepie, Sandrine, Carpentier, Gilles, Maïza, Auriane, Zhang, Ganlin, Vilares, Joao, Raisman-Vozari, Rita, Papy-Garcia, Dulce · 2019 · PLOS ONE
  64. Evidence for the Existence of a Secondary Pathway for Fibril Growth during the Aggregation of Tau
    Gayathri Ramachandran, Jayant B. Udgaonkar · 2012 · Journal of Molecular Biology
  65. Structural transitions in tau k18 on micelle binding suggest a hierarchy in the efficacy of individual microtubule‐binding repeats in filament nucleation
    Patrick Barré, David Eliezer · 2013 · Protein Science
  66. The twenty-four KDa C-terminal tau fragment increases with aging in tauopathy mice: implications of prion-like properties
    Matsumoto, Shin-Ei, Motoi, Yumiko, Ishiguro, Koichi, Tabira, Takeshi, Kametani, Fuyuki, Hasegawa, Masato, Hattori, Nobutaka · 2015 · Human Molecular Genetics
  67. Oligomer Diversity during the Aggregation of the Repeat Region of Tau
    Magnus Kjærgaard, Alexander J. Dear, Franziska Kundel, Seema Qamar, Georg Meisl, Tuomas P. J. Knowles, David Klenerman · 2018 · ACS Chemical Neuroscience
  68. Tau Protein Assembles into Isoform- and Disulfide-dependent Polymorphic Fibrils with Distinct Structural Properties
    Yoshiaki Furukawa, Kumi Kaneko, Nobuyuki Nukina · 2011 · Journal of Biological Chemistry
  69. Structural memory of natively unfolded tau protein detected by small‐angle X‐ray scattering
    Alexander V. Shkumatov, Subashchandrabose Chinnathambi, Eckhard Mandelkow�, Dmitri I. Svergun · 2011 · Proteins Structure Function and Bioinformatics
  70. Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease
    Kunié Ando, Karen Tomimura, Véronique Sazdovitch, Valérie Suain, Zehra Yilmaz, Michèle Authelet, Marième Ndjim, Cristina Vergara, Mounir Belkouch, Marie‐Claude Potier et al. · 2016 · Neurobiology of Disease
  71. Hierarchical Phosphorylation of Recombinant Tau by the Paired‐Helical Filament‐Associated Protein Kinase Is Dependent on Cyclic AMP‐Dependent Protein Kinase
    Gregory A. Jicha, Audrey O' Donnell, C. Weaver, R. Angeletti, P. Davies · 1999 · Journal of Neurochemistry
  72. Tau Aggregation in Alzheimer's Disease: What Role for Phosphorylation?
    Lippens, Guy, Sillen, Alain, Landrieu, Isabelle, Amniai, Laziza, Sibille, Nathalie, Barbier, Pascale, Leroy, Arnaud, Hanoulle, Xavier, Wieruszeski, Jean-Michel · 2007 · Prion
  73. The Molecular Pathology of Alzheimer's Disease
    Charles R. Harrington · 2012 · Neuroimaging Clinics of North America
  74. Evolution from pretangle neurons to neurofibrillary tangles monitored by thiazin red combined with Gallyas method and double immunofluorescence
    Toshiki Uchihara, Ayako Nakamura, Mineo Yamazaki, Osamu Mori · 2001 · Acta Neuropathologica
  75. Role of glycosaminoglycans in determining the helicity of paired helical filaments.
    Montserrat Arrasate, Mar Pérez, José Valpuesta, Jesús Ávila · 1997 · Europe PMC (PubMed Central)
  76. Proliferation of Tau 304–380 Fragment Aggregates through Autocatalytic Secondary Nucleation
    Diana C. Rodriguez Camargo, Eimantas Šileikis, Sean Chia, Emil Axell, Katja Bernfur, Rodrigo Cataldi, Samuel I. A. Cohen, Georg Meisl, Johnny Habchi, Tuomas P. J. Knowles et al. · 2021 · ACS Chemical Neuroscience
  77. Characterization of Neuronal Tau Protein as a Target of Extracellular Signal-regulated Kinase
    Haoling Qi, Sudhakaran Prabakaran, François‐Xavier Cantrelle, Béatrice Chambraud, Jeremy Gunawardena, Guy M. Lippens, Isabelle Landrieu · 2016 · Journal of Biological Chemistry
  78. Tau and neurodegeneration
    Michel Goedert, R. Anthony Crowther, Sjors H. W. Scheres, Maria Grazia Spillantini · 2023 · Cytoskeleton
  79. Amyloidogenesis recapitulated in cell culture: a peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy
    Elena C. Elimova, Robert Kisilevsky, Walter A. Szarek, John B. Ancsin · 2004 · The FASEB Journal
  80. Kinetic Analysis of Amyloid Formation in the Presence of Heparan Sulfate
    Neda Motamedi‐Shad, Élodie Monsellier, Silvia Torrassa, Annalisa Relini, Fabrizio Chiti · 2009 · Journal of Biological Chemistry
  81. Prion-like mechanisms and potential therapeutic targets in neurodegenerative disorders
    Masato Hasegawa, Takashi Nonaka, Masami Masuda‐Suzukake · 2016 · Pharmacology & Therapeutics
  82. Hsp70 Alters Tau Function and Aggregation in an Isoform Specific Manner
    Kellen Voss, Benjamin Combs, Kristina R. Patterson, Lester I. Binder, T.C. Gamblin · 2012 · Biochemistry
  83. Three- and Four-repeat Tau Coassemble into Heterogeneous Filaments
    Ayisha Siddiqua, Martin Margittai · 2010 · Journal of Biological Chemistry
  84. Hyperphosphorylation Results in Tau Dysfunction in DNA Folding and Protection
    Yang Lü, Hai-Jin He, Jun Zhou, Jun-Ye MIAO, Jing Lü, Ying-Ge He, Rong Pan, Wei Yan, Ying Min Liu, Rongqiao He · 2013 · Journal of Alzheimer s Disease
  85. Transgenic animals relevant to Alzheimer’s disease
    Guy R. Seabrook, Thomas W. Rosahl · 1999 · Neuropharmacology
  86. Transglutaminase-Induced Cross-Linking of Tau Proteins in Progressive Supranuclear Palsy
    Magdalena O. Zemaitaitis, John Michael Lee, Juan Carlos Troncoso, Nancy A. Muma · 2000 · Journal of Neuropathology & Experimental Neurology
  87. RNA modulates hnRNPA1A amyloid formation mediated by biomolecular condensates
    Chiara Morelli, Lenka Faltova, Umberto Capasso Palmiero, Katarzyna Makasewicz, Marcell Papp, Raphaël P. B. Jacquat, Dorothea Pinotsi, Paolo Arosio · 2024 · Nature Chemistry
  88. The Enigma of Tau Protein Aggregation: Mechanistic Insights and Future Challenges
    Huiting Zheng, Huimin Sun, Qixu Cai, Hwan‐Ching Tai · 2024 · International Journal of Molecular Sciences
  89. FRET-based Tau seeding assay does not represent prion-like templated assembly of Tau filaments
    Senthilvelrajan Kaniyappan, Katharina Tepper, Jacek Biernat, RamReddy Chandupatla, Sabrina Hübschmann, Stephan H. Irsen, Sandra Bicher, Christoph Klatt, Eva‐Maria Mandelkow, Eckhard Mandelkow� · 2020 · Molecular Neurodegeneration
  90. The elusive tau molecular structures: can we translate the recent breakthroughs into new targets for intervention?
    Yann Fichou, Youssra K. Al‐Hilaly, François Devred, Caroline Smet‐Nocca, Philipp O. Tsvetkov, Joke Verelst, Joris Winderickx, Nick Geukens, Eugeen Vanmechelen, Audrey Perrotin et al. · 2019 · Acta Neuropathologica Communications
  91. Intracellular and Extracellular Roles for Tau in Neurodegenerative Disease
    Diane P. Hanger, Dawn H. W. Lau, Emma Claire Phillips, Marie K. Bondulich, Tong Guo, Benjamin W. Woodward, Amy M. Pooler, Wendy J. Noble · 2014 · Journal of Alzheimer s Disease
  92. What is the pathological significance of tau oligomers?
    Catherine M. Cowan, Shmma Quraishe, Amritpal K. Mudher · 2012 · Biochemical Society Transactions
  93. The ordered assembly of tau is the gain‐of‐toxic function that causes human tauopathies
    Michel Goedert · 2016 · Alzheimer s & Dementia
  94. Sulphated glycosaminoglycans prevent the neurotoxicity of a human prion protein fragment
    Mar Pérez, Francisco G. Wandosell, Camilo A.L.S. Colaco, Jesús Ávila · 1998 · Biochemical Journal
  95. The role of tau in Alzheimer's disease
    Trojanowski, John Q, Lee, Virginia M.-Y · 2002 · Medical Clinics of North America
  96. Heparin Induces Harmless Fibril Formation in Amyloidogenic W7FW14F Apomyoglobin and Amyloid Aggregation in Wild-Type Protein In Vitro
    Silvia Vilasi, Rosalba Sarcina, Rosa Maritato, Antonella Simone, Gaetano Irace, Ivana Sirangelo · 2011 · PLoS ONE
  97. Role of Oxidative Damage in Protein Aggregation Associated with Parkinson's Disease and Related Disorders
    Erin H. Norris, Benoit I. Giasson · 2005 · Antioxidants and Redox Signaling
  98. A novel tau mutation in exon 9 (1260V) causes a four-repeat tauopathy
    Andrew Grover, Elisabet England, Mathew Baker, Naruhiko Sahara, Jennifer L. Adamson, Brian Granger, Henry Houlden, Ulla Passant, Shu-Hui C. Yen, Michael A. Deture et al. · 2003 · Experimental Neurology
  99. Tau Filament Self-Assembly and Structure: Tau as a Therapeutic Target
    Sebastian Scott Oakley, Mahmoud Bukar Maina, Karen E. Marshall, Youssra K. Al‐Hilaly, Charlie Harrington, Claude M. Wischik, Louise C. Serpell · 2020 · Frontiers in Neurology
  100. Tau and Membranes: Interactions That Promote Folding and Condensation
    Chad A. Sallaberry, Barbie J. Voss, Jaroslaw P. Majewski, Jacek Biernat, Eckhard Mandelkow�, Eva Y. Chi, Crystal M. Vander Zanden · 2021 · Frontiers in Cell and Developmental Biology